| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3181247 | Actas Dermo-Sifiliográficas | 2009 | 15 Pages |
Abstract
IL-2 may be an effective and well-tolerated treatment option in patients with satellitosis and cutaneous metastases from melanoma. Lesions smaller than 2 cm and located in the epidermis or superficial dermis respond better than those larger than 2 cm or located in the subcutaneous cellular tissue. More studies are necessary to establish appropriate doses and regimens.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
L.A. Dehesa, J. Vilar-Alejo, P. Valerón-Almazán, G. Carretero,